BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16968481)

  • 1. Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis.
    Bryan CF; McDonald SB; Luger AM; Shield CF; Winklhofer FT; Michael Borkon A; Warady BA; Aeder MI; Murillo D
    Clin Transplant; 2006; 20(5):563-70. PubMed ID: 16968481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
    Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A
    Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of low levels of preformed alloantibodies detected by flow cytometry in the first year post-kidney transplantation.
    Michelon T; Schroeder R; Fagundes I; Canabarro R; Sporleder H; Rodrigues H; Silveira J; Montagner J; Garcia V; Neumann J; Graudenz M
    Transplant Proc; 2005; 37(6):2750-2. PubMed ID: 16182800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM antibodies in renal transplantation.
    McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
    Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience.
    Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P
    Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
    Yuan XP; Wang CX; Gao W; Fu Q; He XS
    Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.
    Jordan SC; Vo A; Bunnapradist S; Toyoda M; Peng A; Puliyanda D; Kamil E; Tyan D
    Transplantation; 2003 Aug; 76(4):631-6. PubMed ID: 12973100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody.
    Higgins R; Hathaway M; Lowe D; Lam F; Kashi H; Tan LC; Imray C; Fletcher S; Zehnder D; Chen K; Krishnan N; Hamer R; Briggs D
    Transplantation; 2007 Oct; 84(7):876-84. PubMed ID: 17984841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-exposure to mismatched HLA class I is a significant risk factor for graft loss: multivariable analysis of 259 kidney retransplants.
    House AA; Chang PC; Luke PP; Leckie SH; Howson WT; Ball EJ; Tan AK; Rehman F; Muirhead N; Hollomby DJ; McAlister VC; Hodsman AB; Jevnikar AM
    Transplantation; 2007 Sep; 84(6):722-8. PubMed ID: 17893605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.
    Kayler LK; Farber JL; Colombe B; LaCava D; Friedewald JJ; Ratner LE
    Transpl Int; 2006 Feb; 19(2):128-39. PubMed ID: 16441362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal graft survival is not influenced by a positive flow B-cell crossmatch.
    Bryan CF; Wakefield M; Reese JC; Shield CF; Warady BA; Winklhofer FT; Murillo D
    Clin Transplant; 2007; 21(1):72-9. PubMed ID: 17302594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class I antibodies in patients awaiting kidney transplantation and the association with renal graft survival.
    Wu HH; Tien YC; Huang CI; Chiang YJ; Chu SH; Lai PC
    Transplant Proc; 2008 Sep; 40(7):2191-4. PubMed ID: 18790188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
    Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.